Gsa Capital Partners LLP Immunome Inc. Transaction History
Gsa Capital Partners LLP
- $1.43 Billion
- Q2 2025
A detailed history of Gsa Capital Partners LLP transactions in Immunome Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 76,046 shares of IMNM stock, worth $1.25 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
76,046Holding current value
$1.25 Million% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding IMNM
# of Institutions
147Shares Held
66.5MCall Options Held
44.9KPut Options Held
4.24M-
T. Rowe Price Investment Management, Inc. Baltimore, MD8.28MShares$136 Million0.05% of portfolio
-
Redmile Group, LLC San Francisco, CA4.87MShares$80.3 Million5.51% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.69MShares$77.3 Million0.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.52MShares$74.6 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA4.08MShares$67.3 Million3.27% of portfolio
About Immunome Inc.
- Ticker IMNM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,127,400
- Market Cap $200M
- Description
- Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...